Biocompatibility and biofilm inhibition of N,N-hexyl,methyl-polyethylenimine bonded to Boston Keratoprosthesis materials

Biomaterials

Volumn 32, Issue 34, 2011, Pages 8783-8796

  Behlau, Irmgard ^a,b,e,f   Mukherjee, Koushik ^c,d   Todani, Amit ^a   Tisdale, Ann S ^b   Cade, Fabiano ^a   Wang, Liqiang ^a   Leonard, Elizabeth M ^a   Zakka, Fouad R ^a,f   Gilmore, Michael S ^a,f   Jakobiec, Frederick A ^a,f   Dohlman, Claes H ^a,f   Klibanov, Alexander M ^c,d  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d Massachusetts Institute of Technology Cambridge   (United States)

^e MOUNT AUBURN HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antibacterial; Corneal cytotoxicity; Keratoprosthesis; PMMA; Polyethylenimine (PEI); Titanium

Indexed keywords

ANTERIOR CHAMBER; ANTIBACTERIAL; ANTIBACTERIAL PROPERTIES; BIOFILM FORMATION; CLINICAL ISOLATES; CONTROL MATERIALS; CORNEAL EPITHELIAL CELLS; IN-VITRO; IN-VIVO; INHIBITORY EFFECT; KERATOPROSTHESIS; PMMA; POLYETHYLENIMINES; STAPHYLOCOCCUS AUREUS;

BACTERIA; BIOCOMPATIBILITY; ESTERS; TISSUE; TISSUE CULTURE; TITANIUM;

BIOFILMS;

N,N HEXYL,METHYL POLYETHYLENIMINE; POLY(METHYL METHACRYLATE); POLYMER; TITANIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BIOCOMPATIBILITY; BIOFILM; CHEMICAL BINDING; CONTROLLED STUDY; CORNEA CELL; CYTOTOXICITY; ELECTRON MICROSCOPE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATOPROSTHESIS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; BIOFILMS; CORNEA; POLYETHYLENEIMINE; POLYMETHYL METHACRYLATE; PROSTHESES AND IMPLANTS; RABBITS; STAPHYLOCOCCUS AUREUS; TITANIUM;

ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

EID: 80053096981     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.010     Document Type: Article

References (39)

1. Butany J., Collins M.J. Analysis of prosthetic cardiac devices: a guide for the practicing pathologist. J Clin Pathol 2005, 58:113-124.
2. Baker A.S., Schein O.D. Ocular infections. Infections associated with indwelling medical devices 1989, 75-92. ASM Press, Washington, D.C. A.L. Bisno, F.A. Waldvogel (Eds.).
3. Darouiche R.O. Treatment of infections associated with surgical implants. N Engl J Med 2004, 350:1422-1429.
4. Scott R.D. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention 2009, CDC, [cited 20April2011]; [16 screens]. Available from URL:. http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf.
5. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
6. Fux C.A., Costerton J.W., Stewart P.S., Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005, 13:34-39.
7. Behlau I., Gilmore M.S. Microbial biofilms in ophthalmology and infectious diseases. Arch Ophthalmol 2008, 126:1572-1581.
8. Dohlman C.H., Harissi-Dagher M., Khan B.F., Sippel K., Aquavella J.V., Graney J.M. Introduction to the use of the Boston keratoprosthesis. Expert Rev Ophthalmol 2006, 1:41-48.
9. Harissi-Dagher M., Khan B.F., Schaumberg D.A., Dohlman C.H. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea 2007, 26:564-568.
10. Dohlman C.H., Dudenhofer E.J., Khan B.F., Morneault S. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J 2002, 28:72-74.
11. Durand M.L., Dohlman C.H. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea 2009, 28:896-901.
12. Pineda R., Ament J.D., Tilahun Y., Behlau I., Dohlman C.H. Prospective evaluation of sustaining the Boston Keratoprosthesis in the developing world: a pilot study. Invest Ophthalmol Vis Sci 2009, 50. ARVO E-Abstract 1497. Available at URL:. http://www.iovs.org.
13. Bennett-Guerrero E., Pappas T.N., Koltun W.A., Fleshman J.W., Lin M., Garg J., et al. For the SWIPE 2 Trial Group, Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery. N Engl J Med 2010, 363:1038-1049.
14. Lewis K., Klibanov A.M. Surpassing nature: rational design of sterile-surface materials. Trends Biotechnol 2005, 23:343-348.
15. Klibanov A.M. Permanently microbicidal materials coatings. J Mater Chem 2007, 17:2479-2482.
16. Milovic N.M., Wang J., Lewis K., Klibanov A.M. Immobilized N-alkylated polyethylenimine avidly kills bacteria by rupturing cell membranes with no resistance developed. Biotechnol Bioeng 2005, 90:715-722.
17. Lin J., Tiller J.C., Lee S.B., Lewis K., Klibanov A.M. Insights into bactericidal action of surface-attached poly (vinyl-N-hexylpyridium) chains. Biotechnol Lett 2002, 24:801-805.
18. Lin J., Qui S., Lewis K., Klibanov A.M. Mechanism of bactericidal and fungicidal activities of textiles covalently modified with alkylated polyethylenimine. Biotechnol Bioeng 2003, 83:168-172.
19. Haldar J., An D., Alvarez de Cienfuegos L., Chen J., Klibanov A.M. Polymeric coatings that inactivate both influenza virus and pathogenic bacteria. Proc Natl Acad Sci USA 2006, 103:17667-17671.
20. Booth M.C., Hatter K.L., Miller D., Davis J., Kowalski R., Parks D.W., et al. Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect Immun 1998, 66:356-360.
21. Behlau I, Leonard EM, Heimer SR, Martin JN, Dohlman CH, Gilmore MS. Characterization of keratitis-associated Staphylococcus aureus infections from the Boston area. Ocular Microbiol Immunol Group. E-Abstract 14. Available at URL: http://eyemicrobiology.upmc.com/2008Abstracts/2008OMIGAbstract14.html.
22. Behlau I., Heimer S.R., Leonard E.M., Martin J.N., Dohlman C.H., Gilmore M.S. Staphylococcus aureus-associated keratitis: phenotypic and genotypic characterization. Invest Ophthalmol Vis Sci 2009, 50. ARVO E-Abstract 5113. Available at URL:. http://www.iovs.org.
23. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998, 339:520-532.
24. Ciolino J.B., Hoare T.R., Iwata N.G., Behlau I., Dohlman C.H., Langer R., et al. Drug-eluting contact lens. Invest Ophthalmol Vis Sci 2009, 50:3346-3352.
25. Jefferson K.K., Cramton S.E., Götz F., Pier G.B. Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Mol Microbiol 2003, 48:889-899.
26. Schlievert P.M., Blomster D.A. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 1983, 147:236-242.
27. M7-A7, methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - approved standard-seventh edition 2006, Clinical and Laboratory Standards Institute, CSLI, Wayne, PA.
28. Ito Y., Imanishi Y., Yonezawa K., Kasuga M. Protein-free cell culture on an artificial substrate with covalently immobilized insulin. Proc Natl Acad Sci USA 1996, 93:3598-3601.
29. Nanci A., Wuest J.D., Péru L., Brunet P., Sharma V., Zalzal S., et al. Chemical modification of titanium surfaces for covalent attachment of biological molecules. J Biomed Mater Res 1998, 40:324-335.
30. Christensen G.D., Simpson W.A., Younger J.J., Baddour L.M., Barrett F.F., Melton D.M., et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985, 22:996-1006.
31. Argueso P., Tisdale A., Spurr-Michaud S., Sumiyoshi M., Gipson I.K. Mucin characteristics of human corneal-limbal epithelial cells that exclude the rose bengal anionic dye. Invest Ophthalmol Vis Sci 2006, 47:113-119.
32. Harissi-Dagher M., Beyer J., Dohlman C.H. The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin 2008, 48:43-51.
33. Rice S.A., Koh K.S., Queck S.Y., Labbate M., Lam K.W., Kjelleberg S. Biofilm formation and sloughing in Serratia marcescens are controlled by quorum sensing and nutrient cues. J Bacteriol 2005, 187:3477-3485.
34. Seidl K., Goerke C., Wolz C., Mack D., Berger-Bächi B., Bischoff M. Staphylococcus aureus CcpA affects biofilm formation. Infect Immun 2008, 76:2044-2050.
35. Khalifa Y.M., Davis D., Mamalis N., Moshirfar M. Epithelial growth over the optic surface of the type 1 Boston Keratoprosthesis: histopathology and implications for biointegration. Clin Opthalmol 2010, 4:1069-1071.
36. Shimizu K., Kobayakawa S., Tsuji A., Tochikubo T. Biofilm formation on hydrophilic intraocular lens material. Curr Eye Res 2006, 31:989-997.
37. Lu L., Renach P.S., Kao W.W.-Y. Corneal epithelial wound healing. Exp Biol Med 2001, 226:653-664.
38. Wilhelmus K.R. The Draize eye test. Surv Ophthalmol 2001, 45:493-515.
39. Espana E.M., Acosta A.C., Stoiber J., Fernandez V., Lamar P.D., Villain F.L., et al. Long-term follow-up of a supradescemetic keratoprosthesis in rabbits: an immunofluorescence study. Graefes Arch Clin Exp Ophthalmol 2011, 249:253-260.